TwinBeech Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-38,114
| Closed | -$414K | – | 860 |
|
|
2024
Q2 | $414K | Sell |
38,114
-67,292
| -64% | -$731K | 0.01% | 464 |
|
|
2024
Q1 | $1.98M | Buy |
105,406
+55,468
| +111% | +$1.04M | 0.04% | 344 |
|
|
2023
Q4 | $1.08M | Buy |
+49,938
| New | +$1.08M | 0.02% | 476 |
|
|
2023
Q3 | – | Sell |
-95,417
| Closed | -$4.49M | – | 862 |
|
|
2023
Q2 | $4.49M | Buy |
95,417
+82,316
| +628% | +$3.87M | 0.09% | 255 |
|
|
2023
Q1 | $550K | Buy |
+13,101
| New | +$550K | 0.01% | 501 |
|
|
2022
Q3 | – | Sell |
-15,562
| Closed | -$503K | – | 787 |
|
|
2022
Q2 | $503K | Buy |
+15,562
| New | +$503K | 0.02% | 417 |
|
|
2021
Q3 | – | Sell |
-18,317
| Closed | -$1.04M | – | 733 |
|
|
2021
Q2 | $1.04M | Buy |
+18,317
| New | +$1.04M | 0.13% | 208 |
|
|
2020
Q1 | – | Sell |
-7,274
| Closed | -$525K | – | 440 |
|
|
2019
Q4 | $525K | Buy |
+7,274
| New | +$525K | 0.15% | 208 |
|